Insider Transactions in Q4 2020 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2020
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,880
+30.64%
|
$20,160
$7.18 P/Share
|
|
Nov 19
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
416
-100.0%
|
$19,968
$48.86 P/Share
|
|
Nov 19
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
416
+50.0%
|
$2,496
$6.27 P/Share
|
|
Nov 19
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,680
-0.23%
|
$783,960
$47.15 P/Share
|
|
Nov 19
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,680
+0.92%
|
$0
$0.33 P/Share
|
|
Nov 18
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,680
-0.31%
|
$783,960
$47.61 P/Share
|
|
Nov 18
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,680
+0.92%
|
$0
$0.33 P/Share
|
|
Nov 17
2020
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
16,680
-0.47%
|
$767,280
$46.26 P/Share
|
|
Nov 17
2020
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
16,680
+0.92%
|
$0
$0.33 P/Share
|
|
Nov 16
2020
|
Robert Hershberg Director |
SELL
Open market or private sale
|
Direct |
2,000
-94.43%
|
$96,000
$48.0 P/Share
|
|
Nov 16
2020
|
Robert Hershberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$0
$0.45 P/Share
|
|
Nov 16
2020
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
6,000
-91.84%
|
$282,000
$47.93 P/Share
|
|
Nov 16
2020
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$42,000
$7.8 P/Share
|
|
Nov 16
2020
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-92.4%
|
$94,000
$47.94 P/Share
|
|
Nov 16
2020
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$14,000
$7.8 P/Share
|
|
Nov 11
2020
|
Viking Global Performance LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,500,000
-7.46%
|
$122,500,000
$49.52 P/Share
|
|
Nov 11
2020
|
Viking Global Investors LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,500,000
-7.46%
|
$122,500,000
$49.52 P/Share
|
|
Nov 09
2020
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-66.39%
|
$1,470,000
$49.74 P/Share
|
|
Nov 09
2020
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.18%
|
$180,000
$6.32 P/Share
|
|
Nov 06
2020
|
Lance Baldo Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,250
-93.62%
|
$312,500
$50.9 P/Share
|
|
Nov 06
2020
|
Lance Baldo Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$43,750
$7.8 P/Share
|
|
Nov 06
2020
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,100
-51.46%
|
$566,100
$51.52 P/Share
|
|
Nov 06
2020
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+48.52%
|
$66,600
$6.32 P/Share
|
|
Nov 05
2020
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,100
-73.29%
|
$555,000
$50.44 P/Share
|
|
Nov 05
2020
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+48.52%
|
$66,600
$6.32 P/Share
|
|
Nov 04
2020
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,100
-74.44%
|
$555,000
$50.59 P/Share
|
|
Nov 04
2020
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+48.52%
|
$66,600
$6.32 P/Share
|
|
Nov 02
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
6,772
-92.07%
|
$304,740
$45.81 P/Share
|
|
Nov 02
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
6,772
+34.03%
|
$40,632
$6.79 P/Share
|
|
Oct 26
2020
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
2,880
-39.14%
|
$141,120
$49.54 P/Share
|
|
Oct 26
2020
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,880
+30.64%
|
$20,160
$7.18 P/Share
|
|
Oct 19
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct |
417
-100.0%
|
$21,267
$51.25 P/Share
|
|
Oct 19
2020
|
Sharon Benzeno Chief Commercial Ofc Imm Med |
BUY
Exercise of conversion of derivative security
|
Direct |
417
+50.0%
|
$2,502
$6.27 P/Share
|
|
Oct 16
2020
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,100
-94.24%
|
$566,100
$51.79 P/Share
|
|
Oct 16
2020
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+48.52%
|
$66,600
$6.32 P/Share
|
|
Oct 15
2020
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$102,000
$51.51 P/Share
|
|
Oct 15
2020
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$14,000
$7.8 P/Share
|
|
Oct 15
2020
|
Robert Hershberg Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$102,000
$51.51 P/Share
|
|
Oct 15
2020
|
Robert Hershberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$0
$0.45 P/Share
|
|
Oct 15
2020
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,100
-94.24%
|
$566,100
$51.55 P/Share
|
|
Oct 15
2020
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+48.52%
|
$66,600
$6.32 P/Share
|
|
Oct 14
2020
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
12,000
-69.37%
|
$624,000
$52.78 P/Share
|
|
Oct 14
2020
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$84,000
$7.8 P/Share
|
|
Oct 14
2020
|
Michael J Pellini Director |
SELL
Open market or private sale
|
Direct |
50,000
-78.26%
|
$2,600,000
$52.42 P/Share
|
|
Oct 14
2020
|
Michael J Pellini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$300,000
$6.55 P/Share
|
|
Oct 14
2020
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,100
-74.18%
|
$577,200
$52.36 P/Share
|
|
Oct 14
2020
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,100
+48.52%
|
$66,600
$6.32 P/Share
|
|
Oct 12
2020
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$1,300,000
$52.8 P/Share
|
|
Oct 12
2020
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$175,000
$7.8 P/Share
|
|
Oct 08
2020
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,000
-81.41%
|
$1,500,000
$50.91 P/Share
|